Market Overview:
The global diabetic gastroparesis treatment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, rising awareness about diabetic gastroparesis, and technological advancements in the field of surgical treatment products. Based on type, the global diabetic gastroparesis treatment market is segmented into drugs and surgical treatment products. The drugs segment is further sub-segmented into prokinetics and antiemetics. The prokinetics sub-segment accounted for the largest share of the global diabetic gastroparesis treatment market in 2017 owing to their ability to improve stomach emptying time in patients with diabetes mellitus.
Product Definition:
Diabetic Gastroparesis Treatment is a medical treatment used to improve the symptoms of diabetic gastroparesis. Diabetic gastroparesis is a condition that occurs in people with diabetes mellitus and results in delayed stomach emptying. Symptoms of diabetic gastroparesis include nausea, vomiting, bloating, and abdominal pain. Diabetic Gastroparesis Treatment may include dietary changes, medications to improve stomach emptying, and surgery.
Drugs:
The global drugs, it's usage and growth factor in diabetic gastroparesis treatment market size was valued at USD 1.1 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the major factors contributing towards the growth of this industry globally.
Surgical Treatment Products:
Surgical treatment products and it's usage in diabetic gastroparesis treatment market is segmented on the basis of type and region. On the basis of type, surgical treatment products are classified into Open surgery, endoscopic surgery, laparoscopic surgery & others.
Application Insights:
The hospital pharmacies segment held the largest share of over 60.0% in 2017. This is owing to the presence of a large patient base with gastroparesis and limited treatment options available for them at home. In addition, hospitals have better infrastructure and are more prominent than other healthcare facilities, which has resulted in higher market penetration for this application type.
Drug stores are expected to be the fastest-growing application segment from 2018 to 2030 due to increasing awareness about diabetes complications among individuals above 40 years of age and rising geriatric population across various regions including Middle East & Africa, Central & South America, Asia Pacific etc., which increases demand for long-term medication as compared to short-term therapy prescribed by doctors in outpatient clinics or hospitals.
Regional Analysis:
North America dominated the global diabetic gastroparesis treatment market in 2017. This can be attributed to the presence of a large number of pharmaceutical companies, which are engaged in drug development for treating this condition. In addition, rising prevalence of diabetes is also expected to contribute towards market growth over the forecast period. According to CDC estimates published in 2016, around 29 million people had diabetes and about 7% of adults and 15% of children have been diagnosed with type 1 diabetes since 2000.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period owing to rise in awareness regarding various treatment options available for treating this condition coupled with increasing healthcare expenditure by governments as well as individuals.
Growth Factors:
- Increasing prevalence of diabetes mellitus
- Growing awareness about diabetic gastroparesis and its treatment options
- Rising demand for minimally invasive procedures for the treatment of diabetic gastroparesis
- Technological advancements in the field of diabetic gastroparesis treatment
- increasing number of clinical studies on new drugs and therapies for the treatment of diabetic gastroparesis
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetic Gastroparesis Treatment Market Research Report
By Type
Drugs, Surgical Treatment Products
By Application
Hospital Pharmacies, Private Clinics, Drug Stores, E-Commerce
By Companies
Sumitomo, Johnson & Johnson, Sanofi, Medtronic, Pfizer, Teva, Boston Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
208
Number of Tables & Figures
146
Customization Available
Yes, the report can be customized as per your need.
Global Diabetic Gastroparesis Treatment Market Report Segments:
The global Diabetic Gastroparesis Treatment market is segmented on the basis of:
Types
Drugs, Surgical Treatment Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Private Clinics, Drug Stores, E-Commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sumitomo
- Johnson & Johnson
- Sanofi
- Medtronic
- Pfizer
- Teva
- Boston Scientific
Highlights of The Diabetic Gastroparesis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Drugs
- Surgical Treatment Products
- By Application:
- Hospital Pharmacies
- Private Clinics
- Drug Stores
- E-Commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetic Gastroparesis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetic gastroparesis is a condition that affects the stomach and intestines. It can cause nausea, vomiting, diarrhea, constipation, and weight loss. Treatment for diabetic gastroparesis includes medications to help improve digestion and reduce nausea and vomiting. In some cases surgery may be necessary to correct the blockages in the digestive system.
Some of the major players in the diabetic gastroparesis treatment market are Sumitomo, Johnson & Johnson, Sanofi, Medtronic, Pfizer, Teva, Boston Scientific.
The diabetic gastroparesis treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diabetic Gastroparesis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Diabetic Gastroparesis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Diabetic Gastroparesis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Diabetic Gastroparesis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Diabetic Gastroparesis Treatment Market Size & Forecast, 2020-2028
4.5.1 Diabetic Gastroparesis Treatment Market Size and Y-o-Y Growth
4.5.2 Diabetic Gastroparesis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Drugs
5.2.2 Surgical Treatment Products
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Private Clinics
6.2.3 Drug Stores
6.2.4 E-Commerce
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Diabetic Gastroparesis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Diabetic Gastroparesis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Drugs
9.6.2 Surgical Treatment Products
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Private Clinics
9.10.3 Drug Stores
9.10.4 E-Commerce
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Drugs
10.6.2 Surgical Treatment Products
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Private Clinics
10.10.3 Drug Stores
10.10.4 E-Commerce
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Drugs
11.6.2 Surgical Treatment Products
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Private Clinics
11.10.3 Drug Stores
11.10.4 E-Commerce
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Drugs
12.6.2 Surgical Treatment Products
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Private Clinics
12.10.3 Drug Stores
12.10.4 E-Commerce
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Drugs
13.6.2 Surgical Treatment Products
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Private Clinics
13.10.3 Drug Stores
13.10.4 E-Commerce
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Diabetic Gastroparesis Treatment Market: Competitive Dashboard
14.2 Global Diabetic Gastroparesis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sumitomo
14.3.2 Johnson & Johnson
14.3.3 Sanofi
14.3.4 Medtronic
14.3.5 Pfizer
14.3.6 Teva
14.3.7 Boston Scientific
